Search

Noble E. Jarrell

Examiner (ID: 19030)

Most Active Art Unit
1699
Art Unit(s)
1625, 1699, 1609, 1624, 1622, 1629
Total Applications
1452
Issued Applications
961
Pending Applications
170
Abandoned Applications
340

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 14301355 [patent_doc_number] => 10290812 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-05-14 [patent_title] => Compound for organic photoelectric device and organic photoelectric device image sensor, and electronic device including the same [patent_app_type] => utility [patent_app_number] => 14/951718 [patent_app_country] => US [patent_app_date] => 2015-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 13417 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 184 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14951718 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/951718
Compound for organic photoelectric device and organic photoelectric device image sensor, and electronic device including the same Nov 24, 2015 Issued
Array ( [id] => 13209079 [patent_doc_number] => 10118896 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-11-06 [patent_title] => Antagonists of the kappa opioid receptor [patent_app_type] => utility [patent_app_number] => 15/529290 [patent_app_country] => US [patent_app_date] => 2015-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 18644 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 177 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15529290 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/529290
Antagonists of the kappa opioid receptor Nov 24, 2015 Issued
Array ( [id] => 15227525 [patent_doc_number] => 10501472 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-12-10 [patent_title] => Method to isolate inoscavin a from [patent_app_type] => utility [patent_app_number] => 15/775007 [patent_app_country] => US [patent_app_date] => 2015-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 5 [patent_no_of_words] => 5877 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15775007 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/775007
Method to isolate inoscavin a from Nov 22, 2015 Issued
Array ( [id] => 11908203 [patent_doc_number] => 09777007 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-10-03 [patent_title] => 'Short-acting benzodiazepine salts and their polymorphic forms' [patent_app_type] => utility [patent_app_number] => 14/948889 [patent_app_country] => US [patent_app_date] => 2015-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 64 [patent_figures_cnt] => 68 [patent_no_of_words] => 20065 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14948889 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/948889
Short-acting benzodiazepine salts and their polymorphic forms Nov 22, 2015 Issued
Array ( [id] => 10795365 [patent_doc_number] => 20160141523 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-05-19 [patent_title] => 'LUMINESCENT COMPLEXES AND DISPLAY DEVICES' [patent_app_type] => utility [patent_app_number] => 14/944427 [patent_app_country] => US [patent_app_date] => 2015-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10213 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14944427 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/944427
Luminescent complexes and display devices Nov 17, 2015 Issued
Array ( [id] => 13478947 [patent_doc_number] => 20180291016 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-10-11 [patent_title] => ANTI-HCMV COMPOSITIONS AND METHODS [patent_app_type] => utility [patent_app_number] => 15/525504 [patent_app_country] => US [patent_app_date] => 2015-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17106 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15525504 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/525504
Anti-HCMV compositions and methods Nov 8, 2015 Issued
14/935454 METHOD FOR PREPARING AFATINIB AND INTERMEDIATE THEREOF Nov 8, 2015 Abandoned
Array ( [id] => 10790134 [patent_doc_number] => 20160136290 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-05-19 [patent_title] => 'Phospholipid Ether Analogs as Cancer-Targeting Drug Vehicles' [patent_app_type] => utility [patent_app_number] => 14/934203 [patent_app_country] => US [patent_app_date] => 2015-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 15791 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14934203 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/934203
Phospholipid ether analogs as cancer-targeting drug vehicles Nov 5, 2015 Issued
Array ( [id] => 13461477 [patent_doc_number] => 20180282281 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-10-04 [patent_title] => IMMUNOREGULATORY AGENTS [patent_app_type] => utility [patent_app_number] => 15/524396 [patent_app_country] => US [patent_app_date] => 2015-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 58714 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15524396 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/524396
IMMUNOREGULATORY AGENTS Nov 4, 2015 Abandoned
Array ( [id] => 15225007 [patent_doc_number] => 10500207 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-12-10 [patent_title] => Compounds for the treatment of diseases associated with amyloid or amyloid-like proteins [patent_app_type] => utility [patent_app_number] => 14/930442 [patent_app_country] => US [patent_app_date] => 2015-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 75567 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 168 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14930442 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/930442
Compounds for the treatment of diseases associated with amyloid or amyloid-like proteins Nov 1, 2015 Issued
Array ( [id] => 14558741 [patent_doc_number] => 10347844 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-07-09 [patent_title] => Material for organic electroluminescent device and organic electroluminescent device using the same [patent_app_type] => utility [patent_app_number] => 14/925960 [patent_app_country] => US [patent_app_date] => 2015-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6034 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 204 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14925960 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/925960
Material for organic electroluminescent device and organic electroluminescent device using the same Oct 27, 2015 Issued
Array ( [id] => 11443274 [patent_doc_number] => 20170044295 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-02-16 [patent_title] => 'POLYMERS, SUBSTRATES, METHODS FOR MAKING SUCH, AND DEVICES COMPRISING THE SAME' [patent_app_type] => utility [patent_app_number] => 14/885557 [patent_app_country] => US [patent_app_date] => 2015-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 7440 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14885557 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/885557
POLYMERS, SUBSTRATES, METHODS FOR MAKING SUCH, AND DEVICES COMPRISING THE SAME Oct 15, 2015 Abandoned
Array ( [id] => 12755074 [patent_doc_number] => 20180143525 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-05-24 [patent_title] => PHOTOCHROMIC METAL ORGANIC FRAMEWORKS FOR INKLESS AND ERASABLE PRINTING [patent_app_type] => utility [patent_app_number] => 15/527960 [patent_app_country] => US [patent_app_date] => 2015-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6153 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15527960 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/527960
Photochromic metal organic frameworks for inkless and erasable printing Sep 29, 2015 Issued
Array ( [id] => 12246293 [patent_doc_number] => 09919057 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-03-20 [patent_title] => 'Compounds comprising self-immolative group' [patent_app_type] => utility [patent_app_number] => 14/865778 [patent_app_country] => US [patent_app_date] => 2015-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 22 [patent_no_of_words] => 22045 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14865778 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/865778
Compounds comprising self-immolative group Sep 24, 2015 Issued
Array ( [id] => 12001732 [patent_doc_number] => 20170305887 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-26 [patent_title] => 'ANTI-ENDOTHELIAL LIPASE COMPOUNDS AND METHODS OF USING THE SAME IN THE TREATMENT AND/OR PREVENTION OF CARDIOVASCULAR DISEASES' [patent_app_type] => utility [patent_app_number] => 15/514157 [patent_app_country] => US [patent_app_date] => 2015-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 11123 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15514157 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/514157
Anti-endothelial lipase compounds and methods of using the same in the treatment and/or prevention of cardiovascular diseases Sep 22, 2015 Issued
Array ( [id] => 14700077 [patent_doc_number] => 10377772 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-08-13 [patent_title] => Macrocyclic LRRK2 kinase inhibitors [patent_app_type] => utility [patent_app_number] => 15/511879 [patent_app_country] => US [patent_app_date] => 2015-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47466 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15511879 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/511879
Macrocyclic LRRK2 kinase inhibitors Sep 16, 2015 Issued
Array ( [id] => 11025071 [patent_doc_number] => 20160222026 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-08-04 [patent_title] => 'Dibenzo[B,F][1,4]oxazepin-11-yl-N-Hydroxybenzamides as HDAC Inhibitors' [patent_app_type] => utility [patent_app_number] => 14/853222 [patent_app_country] => US [patent_app_date] => 2015-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 107724 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14853222 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/853222
Dibenzo[B,F][1,4]oxazepin-11-yl-N-Hydroxybenzamides as HDAC Inhibitors Sep 13, 2015 Abandoned
Array ( [id] => 14454183 [patent_doc_number] => 10323043 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-06-18 [patent_title] => Derivatives of macrocyclic N-aryl-tricyclopyrimidine-2-amine polyethers as inhibitors of FTL3 and JAK [patent_app_type] => utility [patent_app_number] => 15/508014 [patent_app_country] => US [patent_app_date] => 2015-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18435 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 315 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15508014 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/508014
Derivatives of macrocyclic N-aryl-tricyclopyrimidine-2-amine polyethers as inhibitors of FTL3 and JAK Sep 1, 2015 Issued
Array ( [id] => 11977467 [patent_doc_number] => 20170281622 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-05 [patent_title] => 'DERIVATIVES OF MACROCYCLIC N-ARYL-2-AMINO-4-ARYL-PYRIMIDINE POLYETHERS AS INHIBITORS OF FTL3 AND JAK' [patent_app_type] => utility [patent_app_number] => 15/508218 [patent_app_country] => US [patent_app_date] => 2015-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27851 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15508218 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/508218
DERIVATIVES OF MACROCYCLIC N-ARYL-2-AMINO-4-ARYL-PYRIMIDINE POLYETHERS AS INHIBITORS OF FTL3 AND JAK Sep 1, 2015 Abandoned
Array ( [id] => 10483248 [patent_doc_number] => 20150368268 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-12-24 [patent_title] => 'PLYMOREPHOUS FORMS III AND IV OF N-BENZOYL - STAUROSPORINE' [patent_app_type] => utility [patent_app_number] => 14/837792 [patent_app_country] => US [patent_app_date] => 2015-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 2898 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14837792 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/837792
Polymorphous forms III and IV of N-benzoyl-staurosporine Aug 26, 2015 Issued
Menu